Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients

BACKGROUND: Hospitalized acutely ill medical patients are at risk for fatal and major thromboembolic events. Whether use of extended-duration primary thromboprophylaxis can prevent such events is unknown. OBJECTIVES: The purpose of this study was to evaluate whether extended-duration rivaroxaban red...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Am Coll Cardiol
Hlavní autoři: Spyropoulos, Alex C., Ageno, Walter, Albers, Gregory W., Elliott, C. Gregory, Halperin, Jonathan L., Hiatt, William R., Maynard, Gregory A., Steg, P. Gabriel, Weitz, Jeffrey I., Lu, Wentao, Spiro, Theodore E., Barnathan, Elliot S., Raskob, Gary. E.
Médium: Artigo
Jazyk:Inglês
Vydáno: The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7308003/
https://ncbi.nlm.nih.gov/pubmed/32586587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2020.04.071
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky